from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3552/-

LFCtreatmentdescriptionclass of inhibitor

-0.476

Amikacinug/mL Amikacintranslation

-0.554

Cap5-10ug/mL Capreomycintranslation

0.271

Rox10-50 ug/mL Roxithromycintranslation

-0.090

SM2-5 ug/mL Streptomycintranslation

0.178

Tet5-10 ug/mL Tetracyclinetranslation

0.032

Rif0.2-5ug/mL Rifampicintranscription

0.021

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.717

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.331

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.369

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.376

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.183

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.488

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.768

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.698

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.559

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.744

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.374

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.705

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.490

KCN5-20 ug/mL Potassium cyaniderespiration

-1.108

NaN30.2-2 mM Sodium aziderespiration

-0.132

Nigericin50 uM Nigericinrespiration

0.483

TRC10-150 ug/mL Triclosanrespiration

-1.262

TRZ10-25 ug/mL Thioridazinerespiration

-0.872

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.475

menadione6-10 ug/mL Menadionerespiration

1.254

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.545

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.330

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.005

NRP_1Non-replicating persistence stage 1dosRassociated

-0.378

Amp0.2mg/mL AmpicillincellWall

-0.440

Cephalexin20-100 ug/mL CephalexincellWall

-0.250

Cerulenin0.32-5 ug/mL CerulenincellWall

0.009

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.308

EMB10-20 ug/mL EthambutolcellWall

-0.348

Eta12-40 ug/mL EthionamidecellWall

0.061

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.778

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.650

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.701

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.233

BZA0.12 mg/mL BenzamidearomaticAmides

0.013

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.050

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.319

H2O24 mM hydrogen peroxideDNAdamaging

-0.199

Levo10 ug/mL LevofloxacinDNAdamaging

0.094

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.611

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.102

UVUV-irradiationDNAdamaging

-0.733

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.498

Antimycin12.5-50 ug/mL Antimycin A?

0.144

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.424

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.168

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.222

PA8240.2-2 ug/mL PA-824?

0.853

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.772

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.030

Verapamil50 uM Verapamil?

-0.171

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.017

methoxatin10-20 ug/mL Methoxatin?